Why the study?
Managing acute PE in hemodynamically stable patients with minimal symptoms remains challenging, especially when complicated by mobile right atrial thrombus.
Does systemic thrombolysis with Alteplase improve right ventricular function and resolve intracardiac thrombus in hemodynamically stable patients with intermediate-high-risk pulmonary embolism and a mobile right atrial thrombus?
Population
A 65-year-old male with acute PE, severe RV dysfunction, and mobile intracardiac thrombus
Design
Case report
Follow-up
2 h
Key result
Early systemic thrombolysis with Alteplase successfully resolved a large mobile thrombus and improved RV function in a patient with intermediate-high-risk pulmonary embolism.
Authors
Loading...
May support early thrombolysis in select stable intermediate-high-risk PE with mobile thrombus; hypothesis-generating and leaves open need for RCTs.
Does systemic thrombolysis with Alteplase improve right ventricular function and resolve intracardiac thrombus in hemodynamically stable patients with intermediate-high-risk pulmonary embolism and a mobile right atrial thrombus?
Early systemic thrombolysis guided by POCUS-TTE may be effective and safe for intermediate-high-risk pulmonary embolism complicated by a mobile intracardiac thrombus, even in hemodynamically stable patients.
Golea et al. (2025) studied this question. Early systemic thrombolysis with Alteplase successfully resolved a large mobile thrombus and improved RV function in a patient with intermediate-high-risk pulmonary embolism.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: